Current Research Projects

Study Title: "Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism"

This clinical research study is investigating the potential of autologous bone marrow-derived stem cells in the treatment of Parkinson's Disease and Parkinson-Plus Syndrome. These debilitating neurodegenerative conditions currently lack effective cures, but emerging research suggests that stem cell therapy may offer a new path toward slowing disease progression and improving quality of life.

This study utilizes a minimally invasive procedure to harvest, process, and deliver a concentrated dose of your own stem cells. This approach is designed to optimize cell viability and ensure patient safety while maximizing potential therapeutic benefits. By participating in this study, you will not only have the opportunity to explore a cutting-edge treatment option but also contribute to advancing our understanding of stem cell therapy in the context of neurodegenerative diseases.

We are seeking individuals with a confirmed diagnosis of Parkinson's Disease or Parkinson-Plus Syndrome who are motivated to explore innovative treatment approaches. Ideal candidates will meet specific eligibility criteria, including age, disease stage, and overall health status. If you are interested in learning more about this clinical trial and determining your eligibility, we encourage you to contact our research team. Your participation could be instrumental in shaping the future of Parkinson's treatment and offering renewed hope to those affected by these challenging conditions.

• Meta and Epigenomics in the Treatment of Parkinson’s and Parkinson’s Plus Diseases

• Standardized Quantification of in-vivo Mesenchymal Stem Cells via TNAP and Flow-Cytometry

• Optimization of Bone Marrow Aspirate in Treatment of Traumatic Brain Injury

• Benefits of Neural-Differentiated MSCs for Treatment of Central Nervous System Disorders